Company

Roche Reports 2% YOY Growth in 2022; Ocrevus and Hemlibra Drive Sales

Company

Merck & Co. Posts 22% YOY Sales Growth; Keytruda and Gardasil Drive Revenues

Company

Takeda Posts Strong Q3 Results, Announces Pipeline Advances in Oncology and Rare Diseases

CompanyDrug

GenScript’s CAR-T Therapy Carvykti Achieves $55M in Sales, Awaits China Approval

CompanyDeals

Zhejiang Gongdong to Acquire Trademark Plastics for Overseas Expansion

Company

Innovent Biologics Posts Strong Q4 Revenues Amid COVID-19 Challenges

CompanyDeals

Shanghai Weimu Medical Raises Pre-Series A+ Funding for Clinical Development

CompanyDeals

MicroPort Endovascular Plans RMB 2.55 Billion Private Placement

CompanyDrug

OcuMension’s Phase I Study for Dry Eye Treatment OT-202 Concludes

Company

Eli Lilly Reports Q4 Financials with COVID-19 Impact and Market Performers

CompanyDeals

Virpax Pharmaceuticals Seeks China Licensing Partner for Non-Opioid Pain Drug Envelta

Company

Novo Nordisk Posts Strong 2022 Results; GLP-1 Therapies Drive Growth